Novo Nordisk

NVO | NYSE | 369 Followers
$52.42 +2.89% $1.47
Follow
Overview Metrics Financials
Loading...

Fair Price

$82.52
Undervalued by 14.7%
To display the fair price of a share, you need to be a member of Bulios Black.

Profile

Novo Nordisk A/S (NVO) is a Danish pharmaceutical company specializing in the development, manufacturing, and sale of medicines for the treatment of diabetes and other endocrine and metabolic disorders. The company is one of the world's leading manufacturers of insulin and insulin-related medications, which are essential for diabetes treatment. Novo Nordisk also offers other pharmaceutical products for the treatment of obesity, hemophilia, and various endocrine disorders. The company emphasizes on research and innovation in the field of diabetes and other endocrine diseases and has long been committed to fighting diabetes and obesity. Novo Nordisk A/S has extensive international operations, and its products are available in more than 170 countries. Shares of Novo Nordisk A/S (NVO) could represent an intriguing investment opportunity for those who believe in the long-term demand for diabetes and metabolic medications.

Feed

1y
Read More

Novo Nordisk A/S je dansko podjetje, ki je pred kratkim predstavilo zdravilo za debelost. Delnice družbe NVO so se v zadnjem mesecu povečale za več kot 20 %, letos pa za več kot 40 %. Zame gre podjetje v dobro smer in tudi poslovanje je odlično, saj debelost trenutno res prizadene veliko ljudi in če bo razvoj tega zdravila v prihodnosti potekal tako dobro kot doslej, bo...
Read more
0
Share
1y
Read More

Novo Nordisk $NVO je včerajšnji dan zaključil z večjo tržno kapitalizacijo kot LVMH, s čimer je postal največje javno podjetje v Evropi. Cena delnice družbe Novo se je zvišala za 1,9 odstotka na 189,3 dolarja, s čimer je tržna kapitalizacija družbe znašala 423 milijard dolarjev.

Ali imate v svojem portfelju delnice družbe $NVO?
0
Share
Don't have an account? Join us

Log in to Bulios

Continue with Google
Continue with Apple
Continue with Facebook
Or use email and password
Reset password
Already a member? Log in

Create Bulios profile

Continue with
Or use email and password
You can use lowercase letters, numbers, and underscores

Why Bulios?

One of the fastest growing investor communities in Europe

Comprehensive data on thousands of stocks from around the world

Current information from global markets and individual companies

Education and exchange of investment experience among investors

Fair prices, portfolio tracker, stock screener and other tools
Menu StockBot
Tracker
Upgrade